IBANDRONATE SODIUM is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Apotex Corp. The primary component is Ibandronate Sodium.
Product ID | 60505-2795_732ed781-ebf5-e545-2137-c9902c2da92e |
NDC | 60505-2795 |
Product Type | Human Prescription Drug |
Proprietary Name | IBANDRONATE SODIUM |
Generic Name | Ibandronate Sodium |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2012-03-19 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA078948 |
Labeler Name | Apotex Corp |
Substance Name | IBANDRONATE SODIUM |
Active Ingredient Strength | 150 mg/1 |
Pharm Classes | Bisphosphonate [EPC],Diphosphonates [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2012-03-19 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA078948 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2012-03-19 |
Ingredient | Strength |
---|---|
IBANDRONATE SODIUM | 150 mg/1 |
SPL SET ID: | dd674424-b151-d7eb-3acf-b1589347f2f7 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
23155-162 | Ibandronate sodium | Ibandronate sodium |
25021-827 | ibandronate sodium | ibandronate sodium |
33342-150 | IBANDRONATE SODIUM | IBANDRONATE SODIUM |
47781-103 | IBANDRONATE SODIUM | IBANDRONATE SODIUM |
51224-008 | IBANDRONATE SODIUM | Ibandronate Sodium |
55111-575 | Ibandronate sodium | Ibandronate sodium |
55150-191 | Ibandronate Sodium | Ibandronate Sodium |
60429-643 | IBANDRONATE SODIUM | IBANDRONATE SODIUM |
60505-2795 | IBANDRONATE SODIUM | IBANDRONATE SODIUM |
60505-6097 | Ibandronate Sodium | ibandronate sodium |
62756-218 | IBANDRONATE SODIUM | IBANDRONATE SODIUM |
65862-237 | Ibandronate Sodium | Ibandronate Sodium |
67457-524 | ibandronate sodium | ibandronate sodium |
0004-0186 | Boniva | ibandronate sodium |
0004-0191 | Boniva | ibandronate sodium |